Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation

Cristiane M. Ida, Derek R. Johnson, Asha A. Nair, Jaime Davila, Thomas M. Kollmeyer, Kay Minn, Numrah M. Fadra, Jessica R. Balcom, Kar Ming A. Fung, Dong Kun Kim, Timothy J. Kaufmann, Benjamin R. Kipp, Kevin C. Halling, Robert B. Jenkins, Caterina Giannini

Research output: Contribution to journalArticlepeer-review


Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a recently described epileptogenic tumor characterized by oligodendroglioma-like components, aberrant CD34 expression, and frequent mitogen-activated protein kinase (MAPK) pathway activation. We molecularly profiled 13 cases with diagnostic histopathological features of PLNTY (10 female; median age, 16 years; range, 5–52). Patients frequently presented with seizures (9 of 12 with available history) and temporal lobe tumors (9 of 13). MAPK pathway activating alterations were identified in all 13 cases. Fusions were present in the 7 youngest patients: FGFR2-CTNNA3 (n = 2), FGFR2-KIAA1598 (FGFR2-SHTN1) (n = 1), FGFR2-INA (n = 1), FGFR2-MPRIP (n = 1), QKI-NTRK2 (n = 1), and KIAA1549-BRAF (n = 1). BRAF V600E mutation was present in 6 patients (17 years or older). Two fusion-positive cases additionally harbored TP53/RB1 abnormalities suggesting biallelic inactivation. Copy number changes predominantly involving whole chromosomes were observed in all 10 evaluated cases, with losses of chromosome 10q occurring with FGFR2-KIAA1598 (SHTN1)/CTNNA3 fusions. The KIAA1549-BRAF and QKI-NTRK2 fusions were associated respectively with a 7q34 deletion and 9q21 duplication. This study shows that despite its name, PLNTY also occurs in older adults, who frequently show BRAF V600E mutation. It also expands the spectrum of the MAPK pathway activating alterations associated with PLNTY and demonstrates recurrent chromosomal copy number changes consistent with chromosomal instability.

Original languageEnglish (US)
Pages (from-to)821-829
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Issue number9
StatePublished - Sep 1 2021


  • BRAF
  • CD34
  • FGFR2
  • KIAA1549
  • NTRK2
  • Polymorphous low-grade neuroepithelial tumor
  • V600E

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway Activation'. Together they form a unique fingerprint.

Cite this